SCHEMBL8766162

SCHEMBL8766162

CCOP(=O)(CN(CCc1ccc(Cl)cc1)c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 3/20 0.42
NR1I2 O75469 1/20 0.40
FDPS P14324 1/20 0.35
GAA P10253 5/20 0.34
KMT2A Q03164 3/20 0.34
LMNA P02545 2/20 0.34
MEN1 O00255 2/20 0.34
RECQL P46063 1/20 0.34
POLB P06746 2/20 0.32
NPC1 O15118 1/20 0.32
AOC3 Q16853 1/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 3/20 0.32
MAPK1 P28482 2/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TSHR P16473 1/20 0.32
F2R P25116 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8766196 0.92 HMGCR (0.36) HMGCRNR1I2FDPSGAAKMT2A
SCHEMBL8766578 0.91 HMGCR (0.44) HMGCRNR1I2GAAKMT2ALMNA
SCHEMBL8766544 0.89 FDPS (0.37) HMGCRNR1I2FDPSGAAKMT2A
SCHEMBL8766494 0.89 HMGCR (0.44) HMGCRNR1I2FDPSGAAKMT2A
SCHEMBL8766481 0.88 FDPS (0.36) HMGCRNR1I2FDPSGAAKMT2A
SCHEMBL8766072 0.86 HMGCR (0.44) HMGCRNR1I2FDPSGAAKMT2A
SCHEMBL8766645 0.85 FDPS (0.41) HMGCRFDPSGAAKMT2ALMNA
SCHEMBL7119208 0.84 HMGCR (0.43) HMGCRNR1I2FDPSGAAKMT2A
SCHEMBL8766155 0.83 HMGCR (0.42) HMGCRNR1I2FDPSGAAKMT2A
SCHEMBL8766151 0.82 ESRRG (0.41) FDPSGAAPOLBNPC1AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP claimed
EP-0559079-A1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR S.A. (CH) 1993-09-08 EP claimed
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP disclosed
US-5424303-A For treating hypercholesterolemia and hyperlipidemia SYMPHAR SA (CH) 1995-06-13 US disclosed
EP-0559079-A1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR S.A. (CH) 1993-09-08 EP disclosed